Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Study: Hepatitis C does not impede HIV treatment
It shows other factors are to blame for blocking recovery of immune system A study on hepatitis C done by researchers at Wake Forest University Baptist Medical Center is adding to the debate about whether the virus stunts or slows the recovery of the

Ninth Las Vegas Hepatitis C Case Confirmed
Another hepatitis C case linked to a closed Las Vegas endoscopy clinic brings the number of confirmed cases of the disease to nine, health officials said. However, the latest patient to test positive for the disease didn't become ill within a six-month

Nev. health official confirms 9th hepatitis case
LAS VEGAS (AP) - A ninth case of hepatitis C has been linked to a Las Vegas medical clinic facing lawsuits from patients alleging it exposed them to the virus by reusing syringes and vials of medicine. A chronic case of the blood-borne liver disease was

UPDATES AND COMMENTARY RSS Feed

Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....

Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....

Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...

Hepatitis C Virus Dynamics In Vivo:
Effect of Ribavirin and Interferon Alfa on Viral Turnover

Fig. 1. Serum HCV RNA and transaminase determinations in patients with chronic hepatitis C responding to antiviral therapy. All patients responding to treatment with (A) 3 × 3 MU rIFN- per week, (B) 3 × 6 MU rIFN- per week, and (C) 3 × 6 MU rIFN- per week plus ribavirin (14 mg/kg/d orally). Therapy was initiated at day 0 and continued throughout the study. Observed HCV RNA (×), ALT (), and AST levels () are indicated. Undetectable serum HCV RNA data are not shown. Lines are calculated from the best-fitting individual parameter sets. The lower edge of each panel indicates the analytical sensitivity. The normal ranges for ALT and AST are 4 to 22 and 4 to 20 U/L, respectively.

 Figure 1

 Figure 2

 Figure 3

Return To Article

Copyright © 1998 by the American Association for the Study of Liver Diseases.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 25 Jul 2008